BOCCUZZI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 3.663
EU - Europa 2.144
AS - Asia 1.119
AF - Africa 30
OC - Oceania 11
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 6.984
Nazione #
US - Stati Uniti d'America 3.610
CN - Cina 771
SE - Svezia 325
UA - Ucraina 282
IE - Irlanda 274
IT - Italia 245
FR - Francia 205
DE - Germania 203
FI - Finlandia 201
KR - Corea 162
GB - Regno Unito 128
PL - Polonia 90
AT - Austria 70
VN - Vietnam 65
CA - Canada 47
JP - Giappone 43
DK - Danimarca 42
BE - Belgio 24
IN - India 22
SN - Senegal 22
AU - Australia 11
GR - Grecia 11
NL - Olanda 11
ES - Italia 10
SG - Singapore 9
UZ - Uzbekistan 9
TW - Taiwan 8
EU - Europa 7
TH - Thailandia 7
RU - Federazione Russa 6
MX - Messico 5
RO - Romania 5
CL - Cile 4
HK - Hong Kong 4
PH - Filippine 4
TR - Turchia 4
BG - Bulgaria 3
BR - Brasile 3
CO - Colombia 3
IR - Iran 3
MU - Mauritius 3
CZ - Repubblica Ceca 2
HR - Croazia 2
HU - Ungheria 2
ID - Indonesia 2
MY - Malesia 2
NG - Nigeria 2
PK - Pakistan 2
BY - Bielorussia 1
CH - Svizzera 1
EG - Egitto 1
GL - Groenlandia 1
LU - Lussemburgo 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 6.984
Città #
Chandler 671
Beijing 613
Ann Arbor 274
Dublin 273
Ashburn 228
Houston 216
Jacksonville 212
Fairfield 147
Villeurbanne 147
Medford 112
Nyköping 102
Princeton 98
Wilmington 98
Dearborn 97
Woodbridge 94
Warsaw 89
Torino 80
Vienna 68
Seattle 62
Cambridge 54
Dong Ket 46
Milan 42
Pisa 40
Boardman 38
Boston 38
New York 27
Redwood City 27
Fremont 26
Toronto 25
Brussels 23
Verona 22
Lachine 18
Norwalk 13
Nanjing 12
Shanghai 12
Washington 12
Chicago 10
Kunming 10
Detroit 9
Guangzhou 9
San Diego 9
Tokyo 9
Xian 8
Zhengzhou 8
Athens 7
Hefei 7
Nanchang 7
Phoenix 7
Fuzhou 6
Seoul 6
Shenyang 6
Des Moines 5
Helsinki 5
San Antonio 5
Chengdu 4
Falls Church 4
Hangzhou 4
London 4
Mazzè 4
Mountain View 4
Silver Spring 4
Tappahannock 4
Turin 4
West Covina 4
Wuhan 4
Almachar 3
Barnsley 3
Bogotá 3
Changsha 3
Greenfield 3
Jinan 3
Madrid 3
Mexico 3
Nanning 3
Queens 3
Saint-Augustin-de-Desmaures 3
San Mateo 3
Santiago 3
Taipei 3
Ardabil 2
Bangkok 2
Bologna 2
Buffalo 2
Buggingen 2
Canberra 2
Catania 2
Charlestown 2
Cheongju-si 2
Chinchvad 2
Chongqing 2
Cremona 2
Denizli 2
Edinburgh 2
Fort Worth 2
Guiyang 2
Harrogate 2
Hong Kong 2
Kuantan 2
Kumar 2
Little Rock 2
Totale 4.417
Nome #
AGEs/RAGE complex upregulates BACE1 via NF-kappaB pathway activation 402
Dysregulation of SREBP2 induces BACE1 expression. 272
Advanced glycation end-products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose drinking mice 252
Cardiac impairment in rabbits fed a high-fat diet is counteracted by dehydroepiandrosterone supplementation 191
Fructose-derived advanced glycation end-products induce a negative crosstalk between lipogenesis and muscle reprogramming in mice through SREBP-1c 185
Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice 172
Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial 154
Epigenetics modifications and therapeutic prospects in human thyroid cancer. 153
Oxidative stress and kidney dysfunction due to ischemia/reperfusion in rat: attenuation by dehydroepiandrosterone. 150
Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells 143
Sex hormone-binding globulin selectively modulates estradiol-regulated genes in MCF-7 cells 121
Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo. 121
Dehydroepiandrosterone pretreatment protects rats against the pro-oxidant and necrogenic effects of carbon tetrachloride. 108
Adrenal androgen action in breast cancer. 105
Oxygen free radical scavenger properties of dehydroepiandrosterone. 99
Dehydroepiandrosterone inhibits the growth of DMBA-induced rat mammary carcinoma via the androgen receptor. 97
Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. 95
Dehydroepiandrosterone antiestrogenic action through androgen receptor in MCF-7 human breast cancer cell line. 92
Dehydroepiandrosterone protects bovine retinal capillary pericytes against glucose toxicity. 92
AGEs up-regulates BACE1 through their interaction with RAGE and NFkB activation. 88
EFFECTS OF PANOBINOSTAT, A NOVEL DEACETYLASE INHIBITOR, IN PRIMARY CULTURES OF ANAPLASTIC THYROID TUMOURS 87
Dihydrotestosterone affects the growth of hormone-unresponsive breast cancer cells: an indirect action. 84
NT2 neurons, a classical model for Alzheimer's disease, are highly susceptible to oxidative stress 84
5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol. 83
Dehydroepiandrosterone administration counteracts oxidative imbalance and advanced glycation end product formation in type 2 diabetic patients 81
Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure 81
EFFETTO DELLE ONDE D’URTO SUL DIFFERENZIAMENTO DI CELLULE STAMINALI MESENCHIMALI IN CELLULE OSTEOPROGENITRICI 79
THE DEACETYLASE INHIBITOR PANOBINOSTAT IS A CYTOTOXIC DRUG AND INDUCER OF IODINE UPTAKE IN ANAPLASTIC THYROID CANCER PRIMARY CULTURES 77
Valproic acid restores ER-alpha and antiestrogen sensitivity to ER-alpha-negative breast cancer cells 76
Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress. 74
Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophy 73
THE DEACETYLASE INHIBITOR PANOBINOSTAT INHIBITS THE INVASIVE ACTIVITY OF ANAPLASTIC THYROID CANCER CELLS 73
Influence of dehydroepiandrosterone and 5-en-androstene-3 beta, 17 beta-diol on the growth of MCF-7 human breast cancer cells induced by 17 beta-estradiol. 71
The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS) 71
Indirect growth inhibition of the MDA-MB-231 hormone-independent breast cancer cell line by dihydrotestosterone. 70
Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats. 70
Histone Deacetylase Inhibition Modulates E-CadherinExpression and Suppresses Migration and Invasion ofAnaplastic Thyroid Cancer Cells 70
Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients 67
LOOKING FOR THE MOLECULAR BRIDGE BETWEEN SEX HORMONE-BINDING GLOBULIN (SHBG) AND BREAST CANCER CELLS 67
Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib 67
AROMATASE FAILS TO MEDIATE THE PROLIFERATIVE EFFECTS OF ADRENAL ANDROGENS ON CULTURED MCF-7 BREAST CANCER CELLS. 66
Breast duct fluid dehydroepiandrosterone sulphate in fibrocystic disease. 66
Dehydroepiandrosterone prevents the decrease in bovine retinal capillary pericytes number induced in vitro by high glucose 65
Ectopic secretion of LH by an endocrine pancreatic tumor 65
Oxidative stress and cardiac fribiosis in diabetics rats 65
Dehydroepiandrosterone in diabetic rats: protection against NFkB activation. 65
Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single istitution in the past five years 65
Oxidative and nitrosative stress in brain mitochondria of diabetic rats 65
ADRENAL ANDROGEN ACTION IN BREAST CANCER 64
Dehydroepiandrosterone concentration in breast cancer tissue is related to its plasma gradient across the mammary gland. 61
High energy shock waves activate 5'-aminolevulinic Acid and increase permeability to Paclitaxel: antitumor effects of a new combined treatment on anaplastic thyroid cancer cells 60
Oxidative Stress Triggers Cardiac Fibrosis in the Heart of Diabetic Rats 60
Dehydroepiandrosterone and diabetic complications 60
Pro-oxidant effect of dehydroepiandrosterone in rats is mediated by PPAR activation. 59
Effect of oxidative stress on muscle wasting in diabetic rats. 58
Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells 57
Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells 57
Dehydroepiandrosterone modulates nuclear factor-kappaB activation in hippocampus of diabetic rats. 57
Oxidative stress-dependent impairment of cardiac-specific transcription factors in experimental diabetes 56
Dehydroepiandrosterone prevents lipid peroxidation and cell growth inhibition induced by high glucose concentration in cultured rat mesangial cells. 55
Effect of synthetic luteinizing hormone releasing hormone (LH-RH) on the release of gonadotropins in Cushing's disease. 55
Diabetes and muscle wasting: regulatory effect of dehydroepiandrosterone. 55
THE pan-DAC INHIBITOR LBH589 INDUCES E-CADHERIN EXPRESSION IN ESTROGEN-RECEPTOR NEGATIVE BREAST CANCER CELLS. 55
Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia 54
SREBP-1c in NAFDL induced by Western-type high-fat diet plus fructose in rats 54
Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation. 54
EFFECTS OF THE pan-DAC INHIBITOR LBH589 IN ESTROGEN SENSITIVE AND INSENSITIVE BREAST CANCER CELLS. 54
Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatment 54
Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta 52
Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells 51
Dehydroepiandrosterone prevents the decrease in bovine retinal capillary pericytes number induced in vitro by high glucose. I 50
THE pan-DAC INHIBITOR LBH589 INDUCES NIS (SODIUM-IODIDE SYMPORTER) EXPRESSION IN BREAST CANCER 49
Protective effect of dehydroepiandrosterone against copper-induced lipid peroxidation in the rat 47
Growth inhibition of DMBA-induced rat mammary carcinomas by the antiandrogen flutamide. 45
Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer. 45
EFFECT OF CYPROTERONE ACETATE THERAPY ON GONADOTROPIN RESPONSE TO SYNTHETIC LUTEINIZING HORMONE RELEASING HORMONE (LH RH) IN GIRLS WITH IDIOPATHIC PRECOCIOUS PUBERTY. 44
Valproic acid induces the expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells 44
THE ANTIANDROGEN FLUTAMIDE INHIBITS GROWTH OF MCF-7 HUMAN BREAST CANCER CELL LINE. 43
Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells. 43
Inhibitory effect of hydroxyflutamide plus tamoxifen on oestradiol-induced growth of MCF-7 breast cancer cells. 42
Ultrasound screening for thyroid carcinoma in childhood cancer survivors: a case series 42
Muscle wasting in diabetic and in tumor-bearing rats: Role of oxidative stress 41
Oxidative stress and eicosanoids in the kidneys of hyperglycemic rats treated with dehydroepiandrosterone. 41
Oxidative stress impairs skeletal muscle repair in diabetic rats 41
Impulsive and basal ACTH secretion phases in normal subjects, in obese subjects with signs of adrenocortical hyperfunction and in hyperthyroid patients. 40
Protective effect of dehydroepiandrosterone against lipid peroxidation in a human liver cell line. 40
Prevention of carbon tetrachloride-induced lipid peroxidation in liver microsomes from dehydroepiandrosterone-pretreated rats. 38
Oxidative derangement in rat synaptosomes induced by hyperglycaemia: restorative effect of dehydroepiandrosterone treatment. 37
Once-a-day neurally stimulated and basal ACTH secretion phases in man and their response to corticoid inhibition. 36
Possibile ruolo terapeutico del deidroepiandrosterone nell' insufficienza surrenalica e nell' invecchiamento 36
Emerging molecular therapies of advanced thyroid cancer. 33
Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines 31
Totale 7.269
Categoria #
all - tutte 19.325
article - articoli 0
book - libri 0
conference - conferenze 2.911
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.236


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019246 0 0 0 0 0 0 0 0 0 40 157 49
2019/20201.104 26 31 88 138 110 201 137 40 121 82 67 63
2020/2021790 66 36 70 46 67 53 64 27 130 71 47 113
2021/2022892 47 35 48 43 40 30 57 47 41 44 180 280
2022/20231.509 180 135 66 185 129 356 109 95 147 17 63 27
2023/2024498 79 115 38 28 57 119 18 37 2 5 0 0
Totale 7.269